DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Prefilled Syringes Market, Analysis & Forecast, 2017-2021 (Focus on Type, Design, Material both (Value & Volume) ...

BD has positioned itself to unlock a new COVID-19 vaccine opportunity by showing its glass prefilled syringes are suitable for use with mRNA shots that need storing at ultralow temperatures. As the ...

DUBLIN--(BUSINESS WIRE)--The "Prefilled Syringes - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Prefilled Syringes was estimated ...

Germany-based Schreiner MediPharm, a global supplier of functional label technology for the healthcare industry, has teamed up with US-based Plas-Tech Engineering, a company specialized in prefillable ...

The new prefilled syringe has the same composition but removes the need for reconstitution. The Food and Drug Administration (FDA) has accepted for review the regulatory application for a new ...

On May 12, the Defense Department and the Health and Human Services Department issued a $138 million contract to ApiJect Systems America to coordinate the production of prefilled syringes in ...

NEW YORK, June 8, 2020 /PRNewswire/ -- The Global Pre Filled Syringes Market is expected to grow from USD 4,215.13 Million in 2018 to USD 6,845.13 Million by the end of 2025 at a Compound Annual ...

NEW YORK, Dec. 2, 2025 /PRNewswire/ -- The Global Prefilled Syringes Market is entering a transformative era driven by biologics expansion, injectable self-administration, automation in fill-finish ...

NEW YORK, May 16, 2024 /PRNewswire/ -- The global pre-filled syringes market size is estimated to grow by USD 3512.4 million from 2023-2027, according to Technavio. The market is estimated to grow at ...

The claim: The Defense Department ordered enough pre-filled syringes with RFID tracking devices to prepare for military-backed, forced coronavirus vaccinations A claim stating that the U.S. government ...

The US Food and Drug Administration (FDA) has approved GSK's Shingrix vaccine (recombinant zoster vaccine or RZV) in a prefilled syringe presentation to prevent shingles (herpes zoster). This ...